Compare Oracle Corporation (ORCL) vs Dr. Reddy's Laboratories Ltd Common Stock (RDY) Price & Performance

Oracle CorporationTrade

Dr. Reddy's Laboratories Ltd Common StockTrade

Price performance (Past 24H)

Key statistics

Oracle Corporation vs Dr. Reddy's Laboratories Ltd Common Stock — how do they compare? Oracle Corporation trades at $128.4 (market cap $434.11B), while Dr. Reddy's Laboratories Ltd Common Stock trades at $12.75 (market cap $10.78B). The key difference: Oracle Corporation is far larger — about 40.3× Dr. Reddy's Laboratories Ltd Common Stock's market cap, and Oracle Corporation pays the higher dividend (1.4%). Which is the better fit depends on your goals — on Pluang, investors hold Oracle Corporation for 73 Days and Dr. Reddy's Laboratories Ltd Common Stock for 0 Days on average.

	ORCL	RDY
Market Cap	$434.11B	$10.78B
Volume	25,917,551	2,724,343
Sector	Technology	Health
52-Week High	$313.00	$15.38
52-Week Low	$114.99	$11.38
Typical Hold Time	73 Days	0 Days
Enterprise Value	$557.92B	$10.68B
Dividend Yield	1.4%	0.65%

View details →View details →

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Oracle Corporation

Oracle (ORCL) trades at $137.40, down 2.92% on the day amid a bearish technical signal, though it has consistently beaten earnings estimates in recent quarters. Revenue grew to $57.40B in 2025 with a net income margin of 26.36%, while analyst consensus remains strongly bullish with a $236.52 price target. Recent news highlights strong AI cloud demand and restructuring efforts to support growth.

The outlook is positive given robust fundamentals and AI-driven revenue acceleration, but risks include high debt levels, competitive pressures, and market volatility. The stock presents a long-term opportunity if execution on AI infrastructure continues, though near-term price weakness reflects investor caution.

Dr. Reddy's Laboratories Ltd Common Stock

No Aura AI signal available yet.

Aura AI is an analytical signal, not financial advice — do your own research.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

ORCL

53% Buy47% Sell

Avg holding period · 73 Days

RDY

100% Buy0% Sell

Avg holding period · 0 Days

Top news

Latest headlines on both assets

ORCL

CoreWeave shares plunge and bond yields spike amid investor fears over AI-related debt risks.CNBC · 19 hours agoBearish Mizuho keeps Oracle price target at $320 despite project delays, sees 123% upside potential.Finbold · 20 hours agoBullish CoreWeave stock drops 10% as bond yields hit 15%, raising concerns over its debt-funded AI growth.24/7 Wall Street · 22 hours agoBearish View details →

RDY

View details →

About Oracle Corporation

Oracle provides database technology and enterprise resource planning, or ERP, software to enterprises around the world. Founded in 1977, Oracle pioneered the first commercial SQL-based relational database management system. Today, Oracle has 430,000 customers in 175 countries, supported by its base of 136,000 employees.

About Dr. Reddy's Laboratories Ltd Common Stock

Dr. Reddy's Laboratories Ltd. develops and manufactures generic medicines, active pharmaceutical ingredients (APIs), biosimilars, and over-the-counter (OTC) products, headquartered in Hyderabad, India, with therapeutic focus areas spanning gastrointestinal, cardiovascular, oncology, and dermatology.